Long-Term Outcomes After Transcatheter Aortic Valve Implantation in High-Risk Patients With Severe Aortic Stenosis

Journal of the American College of Cardiology - Tập 58 - Trang 2130-2138 - 2011
Neil E. Moat1, Peter Ludman2, Mark A. de Belder3, Ben Bridgewater4, Andrew D. Cunningham5, Christopher P. Young6, Martyn Thomas6, Jan Kovac7, Tom Spyt7, Philip A. MacCarthy8, Olaf Wendler8, David Hildick-Smith9, Simon W. Davies1, Uday Trivedi9, Daniel J. Blackman10, Richard D. Levy4, Stephen J.D. Brecker11, Andreas Baumbach12, Tim Daniel13, Huon Gray14
1Royal Brompton and Harefield National Health Service (NHS) Foundation Trust, London, United Kingdom
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
3James Cook University Hospital, Middlesbrough, United Kingdom
4University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom
5Central Cardiac Audit Database, London, United Kingdom
6Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
7University Hospitals Leicester NHS Trust, Leicester, United Kingdom
8King’s College Hospital (King’s Health Partners), London, United Kingdom
9Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, United Kingdom
10Leeds General Infirmary, Leeds, United Kingdom
11St. Georges Hospital London, London, United Kingdom
12Bristol Heart Institute,, Bristol, United Kingdom
13East Midlands Specialised Commissioning Group, Leichester, United Kingdom
14Southampton University Hospitals NHS Trust, Southampton, United Kingdom

Tài liệu tham khảo

Ross, 1968, Aortic stenosis, Circulation, 38, 61 Frank, 1973, Natural history of valvular aortic stenosis, Br Heart J, 35, 41, 10.1136/hrt.35.1.41 Brown, 2009, Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database, J Thoracic Cardiovasc Surg, 137, 82, 10.1016/j.jtcvs.2008.08.015 Bridgewater Cribier, 2002, Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description, Circulation, 106, 3006, 10.1161/01.CIR.0000047200.36165.B8 Cribier, 2006, Treatment of calcific aortic stenosis with the percutaneous heart valve, J Am Coll Cardiol, 47, 214, 10.1016/j.jacc.2006.01.049 Webb, 2007, Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis, Circulation, 116, 755, 10.1161/CIRCULATIONAHA.107.698258 Grube, 2007, Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis, J Am Coll Cardiol, 50, 69, 10.1016/j.jacc.2007.04.047 Walther, 2007, Transapical minimally invasive aortic valve implantation, Circulation, 116, I240, 10.1161/CIRCULATIONAHA.106.677237 Webb, 2009, Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes, Circulation, 119, 3009, 10.1161/CIRCULATIONAHA.108.837807 Eltchaninoff, 2011, Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National CoreValve and Edwards) registry, Eur Heart J, 32, 191, 10.1093/eurheartj/ehq261 Rodés-Cabau, 2008, Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis, Am J Cardiol, 102, 1240, 10.1016/j.amjcard.2008.06.061 Tamburino, 2011, Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis, Circulation, 123, 239, 10.1161/CIRCULATIONAHA.110.946533 Rodés-Cabau, 2010, Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience, J Am Coll Cardiol, 55, 1080, 10.1016/j.jacc.2009.12.014 Thomas, 2010, Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve, Circulation, 122, 62, 10.1161/CIRCULATIONAHA.109.907402 Zahn, 2011, Transcatheter aortic valve implantation: first results from a multi-centre real-world registry, Eur Heart J, 32, 198, 10.1093/eurheartj/ehq339 Piazza, 2008, Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval, EuroIntervention, 4, 242, 10.4244/EIJV4I2A43 Leon, 2010, Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, 363, 1597, 10.1056/NEJMoa1008232 Smith, 2011, Transcatheter versus surgical aortic valve replacement in high risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510 Dewey, 2008, Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement, J Thorac Cardiovasc Surg, 135, 180, 10.1016/j.jtcvs.2007.09.011 Kahlert, 2010, Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study, Circulation, 121, 870, 10.1161/CIRCULATIONAHA.109.855866 Sinhal, 2008, Atrioventricular block after transcatheter balloon expandable aortic valve implantation, J Am Coll Cardiol Intv, 1, 305, 10.1016/j.jcin.2007.12.009 Khawaja, 2011, Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative), Circulation, 123, 951, 10.1161/CIRCULATIONAHA.109.927152 Jilaihawi, 2009, Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis, Am Heart J, 157, 860, 10.1016/j.ahj.2009.02.016 Rajani, 2010, Paravalvular regurgitation one year after transcatheter aortic valve implantation, Catheter Cardiovasc Interv, 75, 868 Van Mieghem, 2010, Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve system: the Rotterdam experience, EuroIntervention, 5, 673, 10.4244/EIJV5I6A111 Ducrocq, 2010, Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome, EuroIntervention, 5, 666, 10.4244/EIJV5I6A110 Tchetche, 2010, Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards SAPIEN and Medtronic CoreValve bioprostheses in a mixed population, EuroIntervention, 5, 659, 10.4244/EIJV5I6A109 Leon, 2011, Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium, J Am Coll Cardiol, 57, 253, 10.1016/j.jacc.2010.12.005